Cognitive Training in the Treatment of AUD
1 other identifier
interventional
59
1 country
1
Brief Summary
Alcohol Use Disorders (AUDs) have a significant public health impact and are highly prevalent in Veterans. Alcohol related brain effects on neurocognition (attention, memory and executive function) reduce ability to benefit from current treatments. These cognitive impairments are especially common in the early phase of recovery, persist over years and get worse with age. Recent research suggests that cognitive remediation therapy (CRT) may improve attention, memory and executive function in other disorders, and the investigators just completed pilot study with AUD Veterans found significantly greater improvements for those receiving CRT. The proposed study examines AUD outcomes and neurocognitive improvements when CRT is combined with a standardized alcohol treatment. The investigators hypothesize that CRT will improve neurocognition and AUD outcomes more than standardized alcohol treatment alone. Findings will determine whether CRT augmentation can benefit Veterans with AUDs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 14, 2016
CompletedFirst Posted
Study publicly available on registry
January 26, 2016
CompletedStudy Start
First participant enrolled
August 22, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2022
CompletedResults Posted
Study results publicly available
August 27, 2024
CompletedAugust 27, 2024
August 1, 2024
5.1 years
January 14, 2016
November 9, 2022
August 22, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Days of Heavy Alcohol Use Assessed by Weekly Time Line Follow-back and Breathalyzer
Heavy alcohol use over 90 days as verified by Time Line Follow-back or breathalyzer findings. Minimum = 0. Maximum = 90. Fewer days is better.
3 months of active treatment
Secondary Outcomes (3)
Days of Heavy Alcohol Use Assessed by Weekly Time Line Follow-back and Breathalyzer
30 days preceding 6 month follow-up, 3 months after active treatment.
Penn Alcohol Craving Scale
6 month follow-up
Neurocognitive Composite Score (Average of T-scores for Measures of Attention, Processing Speed, Memory, Delayed Recall, Executive Function)
Baseline to 6 months
Study Arms (2)
CRT+IDC
EXPERIMENTALCognitive Remediation Therapy for 13 weeks plus Individual Drug Counseling
Computer Game Play+IDC
ACTIVE COMPARATORComputer arcade games for 13 weeks plus Individual Drug Counseling
Interventions
Up to 65 hours of computer based cognitive training of attention, verbal and visual memory, verbal and visual working memory, and executive functions
Eligibility Criteria
You may qualify if:
- Veterans enrolled in VA AUD treatment as usual and Non-Veteran community members in AUD treatment
- Have a primary diagnosis of AUD and are within 30 days of detoxification or last use at time of recruitment
You may not qualify if:
- Other medical illnesses that compromise neurocognition
- Active use of prescribed opioids or benzodiazepines that may hinder new learning
- Commitment to complete active phase and attend follow-up
- No pending incarceration or plans to leave the state
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
VA Connecticut Healthcare System West Haven Campus, West Haven, CT
West Haven, Connecticut, 06516, United States
Limitations and Caveats
Due to the pandemic, recruitment was below the 90 subjects proposed.
Results Point of Contact
- Title
- Morris Bell, Ph.D., Senior Research Career Scientist
- Organization
- VA Connecticut Healthcare System
Study Officials
- PRINCIPAL INVESTIGATOR
Morris D. Bell, PhD
VA Connecticut Healthcare System West Haven Campus, West Haven, CT
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 14, 2016
First Posted
January 26, 2016
Study Start
August 22, 2016
Primary Completion
September 30, 2021
Study Completion
June 30, 2022
Last Updated
August 27, 2024
Results First Posted
August 27, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share